Ad Astra Diagnostics receives 510(k) clearance of QScout™ hematology analyzer, the first to report measures of infection and severity at point-of-care

Posted on by

QScout™ RLD is the first test to report at point-of-care infection-fighting immature granulocytes (IGs), an early marker of sepsis, and neutrophil-to-lymphocyte ratio (NLR), a prognostic marker for several diseases including COVID-19 MORRISVILLE, N.C., Nov. 16, 2023 /PRNewswire/ — Ad…